SMN1 and proximal spinal muscular atrophy: If the results of verification assay confirmed detection of homo- or heterozygous mutations in the SMN1 gene, the mother of the newborn now known to be at risk of developing SMA or known to be a carrier of SMA were informed, and genetic counseling was provided by specialists of the Genetic Medical Center.